Cardinal Health (CAH) : Traders are bullish on Cardinal Health (CAH) as it has outperformed the S&P 500 by a wide margin of 2.4% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.48%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.91% in the last 1 week, and is up 4.95% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
Cardinal Health (NYSE:CAH): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $84.00 and $83.69 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $84.74. The buying momentum continued till the end and the stock did not give up its gains. It closed at $84.36, notching a gain of 0.93% for the day. The total traded volume was 1,492,755 . The stock had closed at $83.58 on the previous day.
The stock has recorded a 20-day Moving Average of 1.8% and the 50-Day Moving Average is 5.91%. Cardinal Health, Inc. is up 10.43% in the last 3-month period. Year-to-Date the stock performance stands at -4.48%.
Cardinal Health (CAH) : Currently there are 11 street experts covering Cardinal Health (CAH) stock. The most bullish and bearish price target for the stock is $111 and $86 respectively for the short term. The average price target of all the analysts comes to $95.36. The estimated standard deviation from the target is $6.83.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.